“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells

€3.03

SKU: product-article-19519 Category: General

Description
Reviews (0)

Description

P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells

Reviews

There are no reviews yet.

Be the first to review “Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells”

You must be logged in to post a review.

Top

Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells

Description

Reviews

Related products

Article: Calendar of events

1 year access Online Belgian Journal of Hematology (BJH)

Article: Highlights in urologic cancer

1 year subscription print edition of the Belgian Journal of Hematology (BJH)